KIRSTEN STUBER: Open Payments
NPI 1376948620 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,266 in 171 payments from 37 companies in 2025. Trend: 2023 $26,674 · 2024 $23,723 · 2025 $12,266
Speaker / faculty: $5,504Food & beverage: $4,993Travel & lodging: $1,469Long term medical supply or device loan: $299
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $7,322 |
| AstraZeneca Pharmaceuticals LP | 15 | $787 |
| Novartis Pharmaceuticals Corporation | 12 | $484 |
| Tempus AI, Inc | 18 | $469 |
| PFIZER INC. | 14 | $327 |
| Syndax Pharmaceuticals, Inc. | 3 | $244 |
| ABBVIE INC. | 7 | $233 |
| Myriad Genetic Laboratories, Inc. | 4 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $213 |
| Regeneron Healthcare Solutions, Inc. | 11 | $190 |
Products named: ZEJULA, JEMPERLI, XT CDX, KISQALI, EPKINLY, MYRISK, FOTIVDA, IMJUDO.
Industry payments across TX — which companies pay providers there.
